By apyxmedical In 2023 Shareholder News, RenuvionPosted January 25, 2023APYX MEDICAL CORPORATION LAUNCHES NEW ‘APYX ONE CONSOLE’ FOR COSMETIC SURGICAL PROCEDURES IN THE UNITED STATES READ MORE
By apyxmedical In 2022 Shareholder News, 2023 Shareholder News, J-Plasma, RenuvionPosted January 10, 2023APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 REVENUE RESULTS READ MORE
By apyxmedical In 2023 Shareholder News, J-Plasma, RenuvionPosted January 3, 2023APYX MEDICAL CORPORATION EMBARKS ON INAUGURAL BRAND CAMPAIGN FOR RENUVION READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Theodoulidis, Application of J‑Plasma in the excision of diaphragmatic lesions as part of complete cytoreduction in patients with advanced ovarian cancer READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Sutton, History of power sources in endoscopic surgery READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Smith, Laparoscopic Surgical Devices: A Review of the Newest Energies and Instruments READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Nguyen, Conservative Management of Placenta Accreta Using Helium Plasma Focused Radiofrequency Energy READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Llarena, Thermal Injury to the Ovary and Uterus in a Porcine Model: A Comparison of Four Energy Sources READ MORE
0 By apyxmedical In Posted December 5, 2022J-Plasma Clinical Reference – Jundt, Evolving Technologies for Tissue Cutting READ MORE
